Studies have revealed that IL-17 levels are higher in patients with autoimmune gastritis, gastrointestinal metaplasia, and atypical hyperplasia, indicating that a prolonged Th17 response may occur prior to the formation of gastric cancer. The gene discussed is IL17A; the disease is gastric cancer.